Epidemiologic aspects of cancer prevention in Germany

被引:0
|
作者
Nikolaus Becker
机构
[1] German Cancer Research Center,
[2] Division of Clinical Epidemiology,undefined
[3] Im Neuenheimer Feld 280,undefined
[4] 69120 Heidelberg,undefined
[5] Germany e-mail: n.becker@dkfz-heidelberg.de Tel.: +49-6221-422385; Fax: +49-6221-422203,undefined
关键词
Key words Attributable risk; Avoidable deaths; Cancer; Epidemiology; Prevention;
D O I
暂无
中图分类号
学科分类号
摘要
In Germany, as in other highly industrialized countries, cancer is the second most common cause of death. With approximately 210,000 individuals dying each year from malignant tumours, roughly one in four deaths in Germany can currently be attributed to cancer. Only in the past few years has there been a slow decline in the age-standardized mortality rates for cancer, even among men. This follows a long period of some decades, during which the mortality steadily increased and then persisted at a high level. The reversal, however, does not mean that the situation is no longer a cause for concern. In fact, for the most common cause of death, namely the cardiovascular diseases, a much greater decrease in mortality has been observed for many years now. If this trend continues, cancer could become the largest killer in another 15 to 20 years. On the other hand, we have been aware since the end of the 1960s that the majority of cancers are caused by environmental influences and are thus, in principle, avoidable. In the present contribution we present: (a) the fundamental arguments to support the thesis that a large proportion of cancers, and of cancer deaths, could be avoided; and (b) an estimate for Germany of both the theoretical potential of primary cancer prevention and also the practically attainable potential. The estimates are based on very conservative assumptions. They yield, for the theoretical potential, values in the range 43–65% and for the reduction actually obtainable in the medium term due to primary prevention, values of 18–31%.
引用
收藏
页码:9 / 19
页数:10
相关论文
共 50 条
  • [1] Epidemiologic aspects of cancer prevention in Germany
    Becker, N
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 9 - 19
  • [2] EPIDEMIOLOGIC ASPECTS OF CANCER PREVENTION WITH VITAMINS
    ZARIDZE, DG
    BUKIN, YV
    VOPROSY ONKOLOGII, 1990, 36 (06) : 643 - 652
  • [3] EPIDEMIOLOGIC ASPECTS OF GLOBAL BLINDNESS PREVENTION
    THYLEFORS, B
    NEGREL, AD
    PARARAJASEGARAM, R
    CURRENT OPINION IN OPHTHALMOLOGY, 1992, 3 (06) : 824 - 834
  • [4] Epidemiologic cancer registration in Germany
    Hentschel, S.
    Pritzkuleit, R.
    Schmid-Hoepfner, S.
    Katalinic, A.
    ONKOLOGE, 2011, 17 (02): : 97 - +
  • [5] Epidemiologic aspects of advanced systemic mastocytosis in Germany
    Schwaab, J.
    Hartmann, Cabral do O. N.
    Jawhar, M.
    Metzgeroth, G.
    Naumann, N.
    Schmid, A.
    Luebke, J.
    Fabarius, A.
    Hofmann, W. -K.
    Sotlar, K.
    Horny, H. -P.
    Panse, J.
    Reiter, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 228 - 228
  • [6] Epidemiologic aspects of oral cancer
    Sarode, Gargi
    Maniyar, Nikunj
    Sarode, Sachin C.
    Jafer, Mohammed
    Patil, Shankargouda
    Awan, Kamran Habib
    DM DISEASE-A-MONTH, 2020, 66 (12):
  • [7] Gastric Cancer: Epidemiologic Aspects
    Gonzalez, Carlos A.
    Sala, Nuria
    Rokkas, Theodore
    HELICOBACTER, 2013, 18 : 34 - 38
  • [8] CANCER OF THE RECTUM - EPIDEMIOLOGIC ASPECTS
    MATUCHANSKY, C
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1993, 29 (03): : 124 - 125
  • [9] EPIDEMIOLOGIC ASPECTS OF CANCER OF THE CERVIX
    LOMBARD, HL
    NEW ENGLAND JOURNAL OF MEDICINE, 1951, 244 (13): : 492 - 492
  • [10] EPIDEMIOLOGIC ASPECTS OF ESOPHAGEAL CANCER
    MUNOZ, N
    ENDOSCOPY, 1993, 25 (09) : 609 - 612